Tigerstedt, R., Bergman, P.G.: Niere und Kreislauf. Scand. Arch. Physiol., 8: 223-271, 1898.
2.
Goldblatt, H. , Lynch, J., Hanzal, R.F., et al.: Studies on experimental hypertension. I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J. Exp. Med., 59: 347-379, 1934.
3.
Page, I.H., Helmer, O.M.: A crystalline pressor substance (angiotonin) resulting from the reaction between renin and renin-activator. J. Exp. Med., 71: 29, 1940.
4.
Braun-Menendez, E., Fasciolo, J.C., Leloir, J.F., et al.: The substance causing renal hypertension . J. Physiol., 98: 283, 1940.
5.
Eliot, D.F., Peart, W.S.: Amino acid sequence in a hypertensin. Nature, 177: 527, 1956.
6.
Sancho, J., Re, R., Burton, J., et al.: The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects. Circulation, 53: 400-405, 1976.
7.
Geyskes, G.G. , Vos, J., Boer, P., et al.: Renin dependency of blood pressure: Analysis by angiotensin II antagonist P113 in hypertensive patients treated with salt depletion and propranolol. Lancet, 1: 1049-1051, 1976.
8.
Barger, C.: Renin-angiotensin-sodium nervous system interaction in hypertension. Presented at the 23rd annual meeting of the American College of Angiology, Newport Beach, California, January 23-28, 1977.
9.
Abe, K., Irokawa, N., Aoyagi, H., et al.: Circulating renin in essential hypertension: An evaluation of its significance in the Japanese population. Am. Heart J., 89: 723-730, 1975.
10.
Kem, D.C., Kramer, N.J., Gomez-Sanchez, C., et al.: The low renin state: Definition and implications. J. Clin. Invest., 52: 46a-47a, 1973.
11.
Newton, M.A. , Sealey, J.E., Ledingham, J.G.G., et al.: High blood pressure and oral contraceptives: Changes in plasma renin and renin substrate and in aldosterone secretion. Am. J. Obstet. Gynecol., 101: 1037-1045, 1968.
12.
Kuchel, O., Fishman, L.M., Liddle, G.W., et al.: Effect of diazoxide on plasma renin activity in hypertensive patients. Ann. Intern. Med., 67: 791-799, 1967.
13.
Weber, M.A., Case, D.B., Baer, L., et al.: Renin and aldosterone suppression in the antihypertensive action of clonidine. Am. J. Cardiol., 38: 825-830, 1976.
14.
Hall, P.M., Dustan, H.P., Tarazi, R.C.: Suppression of renin release by intravascular volume expansion during chronic diuretic treatment. Cleve Clin Q, 41: 5-14, 1974.
15.
Haber, E.: Recent developments in pathophysiologic studies of the renin-angiotensin system . N. Engl. J. Med., 280: 148-155, 1969.
16.
Gordon, R.D. , Wolfe, L.K., Island, D.P., et al.: A diurnal rhythm in plasma renin activity in man. J. Clin. Invest., 45: 1587-1592, 1966.
17.
Vertes, V., Cangiano, J.L., Berman, L.B., et al.: Hypertension in end-stage renal disease. N. Engl. J. Med., 280: 978-981, 1969.
18.
Weidmann, P. , Maxwell, M.H., Lupu, A.N., et al.: Plasma renin activity and blood pressure in terminal renal failure. N. Engl. J. Med., 285: 757-762, 1971.
19.
Mroczek, W.J. : Malignant hypertension: Kidneys too good to be extirpated. Ann. Intern. Med., 80: 754-757, 1974.
20.
Strong, C.G. , Hunt, J.C., Sheps, S.G., et al.: Renal venous renin activity: Enhancement of sensitivity of lateralization by sodium depletion. Am. J. Cardiol., 27: 602-611, 1971.
21.
Conn, J.W., Cohen, E.L., Lucas, C.P., et al.: Primary reninism: Hypertension, hyperreninemia, and secondary aldosteronism due to renin-producing juxtaglomerular cell tumors. Arch. Intern. Med., 130: 682-696, 1972.
22.
Brunner, H.R. , Laragh, J.H., Baer, L., et al.: Essential hypertension: Renin and aldosterone, heart attack and stroke. N. Engl. J. Med., 286: 441-449, 1972.
23.
Mroczek, W.J. , Finnerty, F.A., Catt, K.J.: Lack of association between plasma-renin and history of heart attack or stroke in patients with essential hypertension . Lancet, 2: 464-469, 1973.
24.
Doyle, A.E. , Jerums, G., Johnston, C.I., et al.: Plasma renin levels and vascular complications in hypertension. Br. Med. J., 2: 206-207, 1973.
25.
Stroobandt, R., Fagard, R., Amery, A.K.P.C.: Are patients with essential hypertension and low renin protected against stroke and heart attack? Am. Heart J., 86: 781-787, 1973.
26.
Buhler, F.R., Laragh, J.H., Vaughan, E.D., et al.: The antihypertensive action of propranolol: Specific antirenin responses in high and normal renin forms of essential, renal, renovascular, and malignant hypertension, In Hypertension Manual. Edited by J. H. Laragh.New York, Yorke Medical Books, 1974, pp. 873-898.
27.
Woods, J.W. , Pittman, A.W., Pullman, C.C., et al.: Renin profiling in hypertension and its use in treatment with propranolol and chlorthalidone. N. Engl. J. Med., 294: 1137-1143, 1976 .
28.
Hollifield, J.W., Sherman, F., Zwagg, R.V., et al.: Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension. N. Engl. J. Med., 295: 68-73, 1976.
29.
Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure, 1976.
30.
Brunner, H.R. , Gavras, H.: Clinical implications of renin in the hypertensive patient. J.A.M.A., 233: 1091-1093, 1975 .
31.
Case, D.B., Wallace, J.M., Keim, H.J., et al.: Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. N. Engl. J. Med., 296: 641-646, 1977.
32.
Wallach, L. , Nyarai, I., Dawson, K.G.: Stimulated renin: A screening test for hypertension. Ann. Intern. Med., 82: 27-34, 1975.